Alphatec Holdings, Inc. (NASDAQ:ATEC) EVP Sells $2,296,745.48 in Stock

Alphatec Holdings, Inc. (NASDAQ:ATEC) EVP Craig E. Hunsaker sold 186,122 shares of the business’s stock in a transaction dated Wednesday, June 4th. The shares were sold at an average price of $12.34, for a total value of $2,296,745.48. Following the completion of the transaction, the executive vice president now owns 1,463,896 shares in the company, valued at $18,064,476.64. The trade was a 11.28% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink.

Alphatec Trading Up 2.3%

Shares of ATEC stock opened at $12.73 on Friday. Alphatec Holdings, Inc. has a 12-month low of $4.88 and a 12-month high of $13.14. The company has a current ratio of 2.32, a quick ratio of 1.15 and a debt-to-equity ratio of 30.21. The stock’s 50-day moving average price is $11.52 and its 200-day moving average price is $10.77. The stock has a market capitalization of $1.86 billion, a price-to-earnings ratio of -9.95 and a beta of 1.10.

Alphatec (NASDAQ:ATEC) last issued its earnings results on Thursday, May 1st. The medical technology company reported ($0.35) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by ($0.23). Alphatec had a negative return on equity of 541.39% and a negative net margin of 31.06%. The firm had revenue of $169.18 million during the quarter, compared to the consensus estimate of $167.57 million. During the same period last year, the firm posted ($0.34) earnings per share. The company’s revenue for the quarter was up 22.2% compared to the same quarter last year. Equities research analysts predict that Alphatec Holdings, Inc. will post -1.08 EPS for the current fiscal year.

Institutional Investors Weigh In On Alphatec

Several large investors have recently added to or reduced their stakes in ATEC. Comerica Bank increased its stake in Alphatec by 66.8% during the fourth quarter. Comerica Bank now owns 3,116 shares of the medical technology company’s stock worth $29,000 after acquiring an additional 1,248 shares during the last quarter. Quarry LP increased its stake in Alphatec by 79.2% during the fourth quarter. Quarry LP now owns 5,374 shares of the medical technology company’s stock worth $49,000 after acquiring an additional 2,375 shares during the last quarter. Larson Financial Group LLC bought a new stake in Alphatec during the first quarter worth approximately $54,000. Lazard Asset Management LLC bought a new stake in Alphatec during the fourth quarter worth approximately $76,000. Finally, AlphaQuest LLC bought a new stake in Alphatec during the fourth quarter worth approximately $80,000. 66.35% of the stock is owned by institutional investors.

Analysts Set New Price Targets

Several brokerages have recently commented on ATEC. Needham & Company LLC restated a “buy” rating and issued a $16.00 price objective on shares of Alphatec in a research report on Friday, May 2nd. Wall Street Zen upgraded Alphatec from a “sell” rating to a “hold” rating in a research report on Friday, February 28th. Piper Sandler restated an “overweight” rating and issued a $15.00 price objective (up from $13.00) on shares of Alphatec in a research report on Friday, May 2nd. Finally, HC Wainwright reaffirmed a “buy” rating and issued a $20.00 target price on shares of Alphatec in a report on Monday, April 14th. Two research analysts have rated the stock with a hold rating and eight have assigned a buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $17.89.

About Alphatec

Alphatec Holdings, Inc, a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. It manufactures and sells implants and instruments through third-party suppliers. The company offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; VEA alignment mobile application, which leverages EOS technology to more quickly quantify alignment parameters on a mobile device; SafeOp Neural InformatiX System that automates electromyographic and somatosensory evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.